A recent study suggests that individuals who stop using blockbuster GLP-1 drugs like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who end conventional lifestyle programs.
Findings released in a major health publication points out that while overweight people can lose substantial amounts of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"People buying these medications must be informed of the risk of fast weight regain when the therapy concludes," stated lead investigator Dr. Susan Jebb.
That rate of regain means a return to starting weight in about one and a half years.
Comparing Approaches
The analysis, which reviewed 37 of studies involving over 9,000 of patients, contrasted the outcomes of the injectable medications with other pills.
Researchers emphasize that individuals who shed pounds through dieting typically have a less rapid weight regain—approximately 0.1 kg a month—once they finish.
Understanding the Quick Rebound
Experts propose the way of the drugs is key to understanding the accelerated weight return.
GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production might result in the body to produce less of its endogenous hormone, and could lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics expert.
"Discontinuation of this GLP-1 'fix' means appetite is no longer kept in check, making overeating a significant risk."
A Lifelong Condition?
The NHS recommend the injections for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Many experts contend that, given the likelihood of relapse, the therapy might need to be life-long.
This opinion is supported by pharmaceutical companies, who say that the findings "underscore the long-term nature of excess weight," comparing it to managing conditions like hypertension.
User Accounts
Users who have discontinued the medication report a intense resurgence of cravings.
"It was like a trigger that goes on and I was suddenly starving," recalled an individual.
This challenge is exacerbated if users have not adopted sustainable lifestyle or habit changes during therapy.
Significant Interest
Recent estimates suggest that a significant number of adults in the UK have tried these injections in the last 12 months, with interest continuing to grow.
- Adoption is higher among women than males.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion access the drugs through private healthcare rather than the NHS.
In conclusion, researchers emphasize that while these medications are effective agents for weight loss, they are not a magic cure and long-term success hinges on ongoing behavioural changes.
